ORIC Pharmaceuticals, Inc.

NASDAQ:ORIC

10.67 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 001.5380000000000000000000
Kosten van de omzet 0.2720.2610.2630.2570.2590.2530.2470.2210.2470.2510.2290.2170.2220.22900000000
Brutowinst -0.272-0.2611.275-0.257-0.259-0.253-0.247-0.221-0.247-0.251-0.229-0.217-0.222-0.22900000000
Brutowinstmarge 000.8290000000000000000000
Onderzoek- en ontwikkelingskosten 28.9421.9624.48122.38818.78719.51616.29514.72313.83416.82816.74512.89915.51711.69712.1138.8317.7237.2546.965.6325.045.212
Algemene en administratieve kosten 7.0777.036.9476.2946.2056.1625.8245.9716.8626.436.065.5575.544.8564.2973.83.41.9251.8111.4651.3151.134
Verkoop- en marketingkosten 0-0.261-0.2630000000000024.8430000000
Verkoop-, algemene en administratieve kosten 7.0776.7696.6846.2946.2056.1625.8245.9716.8626.436.065.5575.544.8564.2973.83.41.9251.8111.4651.3151.134
Overige kosten 03.9793.0983.2042.0481.733550.4090-11.69700.0150-0.0070.0440.0740.0660.0740.0720.0730.07
Bedrijfskosten 36.01728.72931.16528.68224.99225.67822.11920.69420.69623.25822.80518.45621.05716.55316.4112.63111.1239.1798.7717.0976.3556.346
Bedrijfsresultaat -36.017-28.99-31.428-28.682-24.992-25.678-22.119-25.694-20.696-23.258-22.805-18.456-21.057-16.553-28.282-25.602-11.123-9.179-8.771-7.097-6.355-6.346
Bedrijfsresultaat ratio 00-20.4340000000000000000000
Totaal overige inkomsten en kosten netto 4.0543.9793.0983.2042.0481.7331.2720.8650.4090.099-16.4750.030.0150.044-11.879-12.9270.0740.0660.0740.0720.0730.07
Inkomen voor belasting -31.963-25.011-28.33-25.478-22.944-23.945-20.847-24.829-20.287-23.159-22.771-18.426-21.009-16.509-28.259-25.548-11.024-8.872-8.354-6.549-5.965-6.015
Inkomen voor belasting ratio 00-18.420000000000000000000
Belastingkosten -0.2720.2182.243-0.2570.137-1.986-1.272-0.8650-0.099-0.034-0.03-0.033-0.088-0.03-0.01-0.025-0.548-0.417-0.548-0.39-0.592
Nettowinst -31.963-25.011-28.33-25.478-22.944-21.959-19.575-23.964-20.287-23.06-22.771-18.426-21.009-16.509-28.259-25.548-11.024-8.872-8.354-6.549-5.965-6.015
Nettowinstmarge 00-18.420000000000000000000
WPA (Winst Per Aandeel) -0.45-0.37-0.49-0.44-0.5-0.49-0.49-0.61-0.51-0.58-0.58-0.47-0.57-0.45-0.84-0.84-0.51-0.32-0.44-0.34-0.31-0.31
Verwaterde WPA -0.45-0.37-0.49-0.44-0.5-0.49-0.49-0.61-0.51-0.58-0.58-0.47-0.57-0.45-0.84-0.84-0.51-0.32-0.44-0.34-0.31-0.31
EBITDA -36.017-28.729-31.165-28.682-24.733-25.678-22.119-15.694-20.449-23.007-22.805-18.239-20.835-16.324-4.5380.58-10.877-8.929-8.501-6.827-6.109-6.104
EBITDA ratio 00-20.2630000000000000000000